Home
News
Editorial
MD(e)B(unker)
Related Researches
Di Bella's Foundation
1960-1969
1970-1979
1980-1989
1990-1999
2000-2009
2010-2019
2020-2029
Science news
Scientific Documentation
About us...
Biography
Bibliography
The Method
Di Bella's Method!
1998 Trial!
Media
Video Publications
News-Papers
Press
Testimonial
Testimonies
Video Gallery
Congresses
Video Testimonies
TV & C.
Case History
Lung
Lymphomas
Non-Hodgkin Lymphomas
Hodgkin Lymphomas
Mediastinum
Mesothelioma
Myeloma
Pancreas
Scientific Publications
F.A.Q.
Useful Links
User Side
Vademecum
CouponChief - Resources for Cancer Patients
Contact Us
Home page
News
Related Researches
2000-2009
Title
Created Date
Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis
08 June 2017
Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells
07 June 2017
Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice
06 June 2017
Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kip1) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells
01 June 2017
Autocrine metabolism of vitamin D in normal and malignant breast tissue
01 June 2017
Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours. Correlation with preoperative octreotide scintigraphy
26 May 2017
Expression of somatostatin type 2A receptor correlates with estrogen receptor in human breast carcinoma
25 May 2017
Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase, and vitamin D receptor mRNA in normal and malignant breast tissue
24 May 2017
Expression of somatostatin receptor subtypes and growth inhibition in human exocrine pancreatic cancers
23 May 2017
Evidence that retinoic acid receptor beta induction by retinoids is important for tumor cell growth inhibition
23 May 2017
Display #
5
10
15
20
25
30
50
100
All
Page 47 of 111
Start
Prev
42
43
44
45
46
47
48
49
50
51
Next
End
Search
Follow us...
Latest
Melatonin: A Powerful Integrative Adjunctive Agent for Oncology
Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives
Melatonin in cancer management: progress and promise
Radioprotective effect of melatonin on the cervical spinal cord in irradiated rats
Protective effects of melatonin and vitamin E in brain damage due to gamma radiation: an experimental study
Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities
The impact of vitamin D on cancer: A mini review
Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells
Radio-Protective Effects of Melatonin on Subventricular Zone in Irradiated Rat: Decrease in Apoptosis and Upregulation of Nestin
Modulating effects of famotidine and melatonin on high dose radiation induced cell lethality in normal human and cancer cell lines
Melatonin Sensitizes Human Colorectal Cancer Cells to γ-ray Ionizing Radiation In Vitro and In Vivo
Melatonin: an endogenous miraculous indolamine, fights against cancer progression
Melatonin: An Endogenous Antiestrogen with Oncostatic Properties
Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis
Disease Control after Androgen Deprivation Therapy Combined with Di Bella Multitherapy
Somatostatin and Somatostatin Receptors in Tumour Biology
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation
Most Read
The Di Bella Method (DBM)
About melatonin - 1996
All-trans-retinoic acid and cancer
Biography
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
Somatostatin in oncology, the overlooked evidences
Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
How effective is chemo therapy?
Complete objective response to biological therapy of plurifocal breast carcinoma
Bibliography
Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
Vademecum
Frequently Asked Questions
Declaration recommends eliminate the use of Impact factor for research evaluation
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer